Indication
Anhedonia
7 registered trials testing Psilocybin, Ketamine for this indication, 2 recruiting now.
7
Registered trials
2
Recruiting
0
In Phase 3
Substances tested
Being studied with
Stay told
When a new trial opens
Trials
All 7 trials for Anhedonia
| Trial | Status | Phase | Substance | Sites |
|---|---|---|---|---|
| Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic EffectsNCT07490353 · Medical University of Vienna | Recruiting | Phase 1 | psilocybin | 1 |
| Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant DepressionNCT07146503 · Riccardo Guglielmo | Recruiting | N/A | ketamine | 5 |
| Anhedonia, Development, and Emotions: Phenotyping and TherapeuticsNCT05487885 · Erika Forbes | Completed | Phase 4 | ketamine | 1 |
| Psilocybin for Treatment-Resistant DepressionNCT06230757 · University of Colorado, Denver | Completed | Phase 2 | psilocybin | 1 |
| PET Synaptogenesis After Psilocybin In DEpression RecoveryNCT05601648 · Washington University School of Medicine | Withdrawn | Phase 2 | psilocybin | 1 |
| Psilocybin as a Novel Therapy for Residual AnhedoniaNCT07607938 · NYU Langone Health | Not yet recruiting | Phase 1 | psilocybin | 1 |
| Synaptic Imaging and Network Activity in Treatment Resistant DepressionNCT05870501 · King's College London | Completed | Not applicable | ketamine | 1 |
Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.